Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
554.00    0.00 (0.00%)
Bid:
554.50
Ask:
555.00
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

30 Jan 2020 11:45

RNS Number : 4558B
Tate & Lyle PLC
30 January 2020
Β 

Tate & Lyle PLC

Β 

Notification of transaction by a Person Discharging Managerial Responsibilities

Β 

Tate & Lyle PLC (the "Company") has been informed that Andrew Taylor, a Person Discharging Managerial Responsibilities ("PDMR"), purchased ordinary shares of 25 pence each in the capital of the Company under the dividend reinvestment plan.

Β 

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Β 

Β 

Claire-Marie O'Grady

Company Secretary

30 January 2020

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew Taylor

2.

Reason for the notification

a)

Position / status

PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

Β 

GB0008754136

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 7.65

242

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

242

Β 

GBP 1,851.30

e)

Date of the transaction

2020-01-03

f)

Place of the transaction

London Stock ExchangeXLON

Β 

Β 

Β 

Β 

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew Taylor

2.

Reason for the notification

a)

Position / status

PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

Β 

GB0008754136

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 7.52

283

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

283

Β 

GBP 2,128.16

e)

Date of the transaction

2019-07-31

f)

Place of the transaction

London Stock ExchangeXLON

Β 

Β 

Β 

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew Taylor

2.

Reason for the notification

a)

Position / status

PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

Β 

GB0008754136

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 6.68

130

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

130

Β 

GBP 868.40

e)

Date of the transaction

2019-01-04

f)

Place of the transaction

London Stock ExchangeXLON

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHURUARRAUAOAR
Date   Source Headline
26th Jun 20266:22 pmRNSForm 8.3 TATE & LYLE PLC Replacement
26th Jun 20263:36 pmRNSForm 8.3 - Tate & Lyle plc
26th Jun 20263:12 pmRNSForm 8.3 TATE & LYLE PLC
26th Jun 20263:06 pmRNSForm 8.3 - Tate & Lyle plc
26th Jun 20262:59 pmRNSForm 8.3 - Tate & Lyle plc
26th Jun 20262:57 pmRNSForm 8.3 TATE & LYLE PLC Replacement
26th Jun 20262:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
26th Jun 20261:33 pmRNSForm 8.3 Tate & Lyle Plc
26th Jun 20261:16 pmRNSForm 8.3 Tate & Lyle plc
26th Jun 202612:50 pmRNSForm 8.3 Tate & Lyle Plc
26th Jun 202612:26 pmRNSForm 8.3 - TATE & LYLE PLC
26th Jun 202611:49 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
26th Jun 202611:35 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
26th Jun 202611:23 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
26th Jun 202611:17 amRNS20260625_TATE & LYLE_8.5 EPT RI_UK_MLI
26th Jun 202611:16 amRNS20260625_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
26th Jun 202610:19 amRNSForm 8.3 Tate n Lyle plc
26th Jun 20269:24 amRNSForm 8.5 (EPT/RI)
25th Jun 20263:25 pmRNSForm 8.3 TATE & LYLE PLC
25th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
25th Jun 20262:52 pmRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
25th Jun 20262:47 pmRNSForm 8.3 Tate & Lyle Plc
25th Jun 20262:23 pmRNSForm 8.3 - Tate & Lyle plc
25th Jun 20262:19 pmRNSForm 8.5 (EPT/RI) - Amendment TATE & LYLE PLC
25th Jun 20262:01 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
25th Jun 20261:55 pmRNSForm 8.3 - Tate & Lyle plc
25th Jun 20261:47 pmRNSForm 8.3 Tate & Lyle plc
25th Jun 20261:02 pmRNSForm 8.3 TATE & LYLE PLC
25th Jun 202612:18 pmRNSForm 8.3 - Tate & Lyle PLC
25th Jun 202611:59 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
25th Jun 202611:31 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
25th Jun 202611:19 amRNS20260624_TATE & LYLE_8.5 EPT RI_UK_MLI
25th Jun 202611:18 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
25th Jun 202610:57 amRNSForm 8.5 (EPT/RI)- Tate & Lyle plc
25th Jun 202610:48 amRNSForm 8.3 Tate & Lyle Plc
25th Jun 20269:39 amRNSForm 8.5 (EPT/RI) - Amendment
25th Jun 20269:33 amRNSForm 8.5 (EPT/RI)
24th Jun 20265:24 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
24th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
24th Jun 20263:18 pmRNSForm 8.3 - Tate & Lyle Plc
24th Jun 20263:08 pmRNSForm 8.3 TATE & LYLE PLC
24th Jun 20263:02 pmRNSForm 8.3 - Tate & Lyle plc
24th Jun 20262:56 pmRNSForm 8.3 - Tate & Lyle plc
24th Jun 20262:28 pmRNSForm 8.3 - Tate & Lyle plc
24th Jun 20261:56 pmRNSForm 8.3 TATE & LYLE PLC
24th Jun 20261:52 pmRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
24th Jun 20261:36 pmRNSForm 8.3 - Tate & Lyle plc Replacement
24th Jun 202611:54 amRNSForm 8.3 - Tate and Lyle PLC
24th Jun 202611:35 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
24th Jun 202611:24 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.